5N Plus Operating Income Over Time
| EMB Stock | 18.18 0.60 3.19% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out 5N Plus Performance and 5N Plus Correlation. EMB |
Cross Equities Operating Income Analysis
Compare 5N Plus and related stocks such as ROCHE HLDG, Abbott Laboratories, and DANAHER (DAPSG) Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RHO | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 14.1 B | 13 B | 14.7 B | 17.5 B | 18.5 B | 18.2 B | 17.5 B | 15.4 B | 13.4 B | 18.5 B | 17.7 B |
| ABL | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 1.7 B | 3.6 B | 4.5 B | 5.4 B | 8.4 B | 8.4 B | 6.5 B | 6.8 B | 7.8 B | 5.9 B |
| DAP | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 3 B | 3.4 B | 3.3 B | 4.2 B | 6.4 B | 7.5 B | 5.2 B | 4.9 B | 4.7 B | 5 B |
| QCI | 6.5 B | 6.5 B | 6.5 B | 6.5 B | 6.5 B | 6.5 B | 2.6 B | 742 M | 7.7 B | 6.3 B | 9.8 B | 15.9 B | 8.7 B | 10.3 B | 12.4 B | 14.3 B | 8.9 B |
| 6MK | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 7.3 B | 8.9 B | 12.2 B | 5.5 B | 13.2 B | 18.3 B | 3 B | 20.2 B | 23.3 B | 24.4 B |
| NOT | 11.1 B | 11.1 B | 11.1 B | 11.1 B | 11.1 B | 9 B | 8.3 B | 8.6 B | 8.2 B | 9.1 B | 10.2 B | 10.1 B | 7.9 B | 9.8 B | 14.5 B | 17.6 B | 11.4 B |
| NOT | 8.3 B | 8.3 B | 8.3 B | 8.3 B | 8.3 B | 8.3 B | 8.3 B | 8.6 B | 8.2 B | 9.1 B | 10.2 B | 10.1 B | 7.9 B | 9.8 B | 14.5 B | 17.6 B | 11.5 B |
| AMD | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | 204 M | 451 M | 631 M | 1.4 B | 3.6 B | 1.3 B | 401 M | 2.1 B | 3.7 B | 3.9 B |
| 4I1 | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 11.5 B | 11.3 B | 10.4 B | 11.6 B | 13 B | 12.2 B | 12.2 B | 13.4 B | 14.9 B | 13.4 B |
| W8V | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 198 B | 176 B |
5N Plus and related stocks such as ROCHE HLDG, Abbott Laboratories, and DANAHER (DAPSG) Operating Income description
Operating Income is the amount of profit realized from 5N Plus operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of 5N Plus is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| 5N Plus | EMB |
Specialization | Basic Materials, Specialty Chemicals |
| Business Address | 4385, Garand Street, |
| Exchange | Stuttgart Exchange |
null 18.18
Additional Tools for EMB Stock Analysis
When running 5N Plus' price analysis, check to measure 5N Plus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 5N Plus is operating at the current time. Most of 5N Plus' value examination focuses on studying past and present price action to predict the probability of 5N Plus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 5N Plus' price. Additionally, you may evaluate how the addition of 5N Plus to your portfolios can decrease your overall portfolio volatility.